GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kilitch Drugs India Ltd

Kilitch Drugs India Ltd: Independent Director Resigns

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 21 Oct 2026, 02:01 PM IST  ·  BSE ID: 82e4bb1f-679d-40fc-8095-2de6f3288dd8
View Original BSE Filing (PDF)
💡
In Simple Terms
An independent director has left Kilitch Drugs India Ltd. immediately for personal reasons.
🤖 AI Summary
  • Non-Executive Independent Director Mr. Venkita Subramanian Rajan resigned.
  • Resignation is effective immediately due to personal commitments.
  • Director also resigns from Audit Committee chairmanship.
  • Director also resigns from Nomination and Remuneration Committee chairmanship.
  • Director also resigns from Stakeholder Relationship Committee chairmanship.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will need to appoint a new director and potentially fill committee vacancies.
⚠️
Risk Impact
A departure of an independent director may signal underlying issues, though reasons cited are personal.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are affected by changes in board and committee composition, which oversees company management.
🔍
Management Signal
The resignation highlights the importance of director availability and commitment to their roles and committee responsibilities.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Company announcement regarding new director appointment
Board meeting minutes detailing committee changes
Next quarterly results announcement
LOW RISK Resignation cited personal reasons, not direct company operational or financial concerns.
💡 Investor Takeaway
Kilitch Drugs India Ltd. announced the immediate resignation of Non-Executive Independent Director Mr. Venkita Subramanian Rajan due to personal commitments. He exits committee roles.
❓ Frequently Asked Questions
Who resigned from Kilitch Drugs India Ltd.?
Mr. Venkita Subramanian Rajan has resigned from his position as Non-Executive Independent Director.
When is the resignation effective?
The resignation of Mr. Venkita Subramanian Rajan is effective immediately.
Why did the director resign?
The director resigned citing pre-occupation and other personal commitments.
What committee roles did the director hold?
Mr. Venkita Subramanian Rajan was Chairman and/or Member of the Audit Committee, Nomination and Remuneration Committee, and Stakeholder Relationship Committee.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.